ARS Pharmaceuticals: Pay

ARS Pharmaceuticals paid its one named executive on file $2.9M in FY2025 (Dec).

Pay of each named executive

Justin ChakmaChief Business Officer
FY2025 (Dec)
1 year
Sarina Tanimoto, M.D., M.B.A.Chief Medical Officer
FY2022 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $10.4M. The CEO of ARS Pharmaceuticals was paid $9.7M, 8% below the median.

  1. 1Cogent Biosciences
  2. 2TG Therapeutics
  3. 3Protagonist Therapeutics
  4. 4Mirum Pharmaceuticals
  5. 5ARS Pharmaceuticals
  6. 6Arcutis Biotherapeutics
  7. 7Tarsus Pharmaceuticals
  8. 8Agios Pharmaceuticals
  9. 9Alector, Inc.Not disclosed
  10. 10AnaptysBio, Inc.Not disclosed
  11. 11Avadel Pharmaceuticals plcNot disclosed
  12. 12Day One Biopharmaceuticals, Inc.Not disclosed
  13. 13GeronNot disclosed
  14. 14Iovance Biotherapeutics, Inc.Not disclosed
  15. 15LiquidiaNot disclosed
  16. 16Revance Therapeutics, Inc.Not disclosed
  17. 17Rigel Pharmaceuticals, Inc.Not disclosed
  18. 18Syndax PharmaceuticalsNot disclosed
  19. 19Viridian Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.